IMU imugene limited

0.00%

13.5¢

Weekly chart, page-104

First 104 Last

Share
Profile

Follow
Vivo

72 Posts.

3

21/03/18

08:28

Post #: 31904935
Share

Originally posted by Steini ↑

"The consistent buying pressure recently confuses me because there has been no announcement to warrant it. Is it speculation, artificial or inside?"

Vivo, it is more than likely that one or more bigger players taken a big stake up to the " 10.1 % poison pill " holding which prevents an automatic t/o success at 90 % acceptance which is a common t/o condition. No further anns needed to drive sp higher as we all know how undervalued IMU still is. But to avoid to become a sub holder just using a few accounts will do the trick.

Unlikely that just a few big traders with their "special ASX extra packages deal" mocking around here. The huge daily turnovers compared to last year's records suggests there are one / some real big accumulators working. A $ 500m partnership or / t/o deal would equal to a sp of 17.5 - 20c, no wonder the accumulation level is taken higher as we still operate sub 4c.

Last year a university team in Munich proved that the immune system is capable and always has been capable of killing viruses / bacteria and DNA based modified cells ( due to aging / inheritance / environmentally influenced DNA changes of cells aka as CANCER ). That reduced IMU's task to provide solutions to 2 problems: To reactivate a switched off immune system which has been shut down to avoid an over reaction or to activate a non responsive immune system. Both problems seem to be successfully addressed / solved.

It is easy to kill cancer cells in the lab, harder in rats / mice and almost impossible in humans for most of those who are researching. IMU proofed during phase 1 and now 1b, according to the IMU updates, that there already was a great immune system response at the lowest dosage. The world is aware of that and that drives some bigger pockets to take a stake before a deal or t/o is announced.

No guarantee we will see the 500m market cap but no reasons why not.

IMO 5c very soon, hoping for 10c by end of 2018 depending on anns.

GLTA all current sufferers to stay alive until the vax is available. And don't forget, being cancer free today is no guarantee for not being affected at later stage. It would be a great feeling to know to have supported the team that firstly offered a real treatment / prevention solution to sufferers.

Expand

Thankyou, that was the reply I was looking for. I can't read through what the trading volumes mean etc. But it makes sense if a bigger player is accumulating. I'm not going anywhere.

Last edited by Vivo: 21/03/18

IMU Price at posting: 3.4¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

HotCopper Highlights: Stakk, Northern Star and Imugene dominate discussion

AS2

Askari Metals outlines its African growth strategy and the pathway to drilling at Nejo

ADVFN appoints Jason Paltrowitz as non-executive director

PUR

Pursuit Minerals kicks off drill hole three at Rio Grande Sur lithium project

FG1

Flynn Gold's maiden drilling confirms extensive system at Silver King

GRE

GreenTech Metals readies for Munni Munni and Whundo drill programs

OSL

OncoSil Medical files for US FDA approval for specialist device

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

PSC

Prospect reshapes its Mumbezhi story with 'folded paper' and a 400m gamble

First 104 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 13.5¢		Change 0.000(0.00%)		Mkt cap ! $56.13M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Buyers (Bids)

Vol.	Price($)
285615	13.0¢

Sellers (Offers)

Price($)	Vol.
14.0¢	145434

Last trade - 16.00pm 03/07/2026 (20 minute delay)

IMU (ASX) Chart

Day chart unavailable

Weekly chart, page-104

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

HotCopper Highlights: Stakk, Northern Star and Imugene dominate discussion

Askari Metals outlines its African growth strategy and the pathway to drilling at Nejo

ADVFN appoints Jason Paltrowitz as non-executive director

Pursuit Minerals kicks off drill hole three at Rio Grande Sur lithium project

Flynn Gold's maiden drilling confirms extensive system at Silver King

GreenTech Metals readies for Munni Munni and Whundo drill programs

OncoSil Medical files for US FDA approval for specialist device

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

Prospect reshapes its Mumbezhi story with 'folded paper' and a 400m gamble

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Weekly chart, page-104

Top Stories

Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now

HotCopper Highlights: Stakk, Northern Star and Imugene dominate discussion

Askari Metals outlines its African growth strategy and the pathway to drilling at Nejo

ADVFN appoints Jason Paltrowitz as non-executive director

Pursuit Minerals kicks off drill hole three at Rio Grande Sur lithium project

Flynn Gold's maiden drilling confirms extensive system at Silver King

GreenTech Metals readies for Munni Munni and Whundo drill programs

OncoSil Medical files for US FDA approval for specialist device

LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good

Prospect reshapes its Mumbezhi story with 'folded paper' and a 400m gamble

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News